1 / 24

Global Cancer Supportive Care Products Market - Size, Share, Trends, Analysis to 2021

Globally, cancer supportive care products market is estimated to account for a market value of US$ 24,620 Mn by the end of 2015, and it is projected to witness stable growth across all global regions, due to rising incidences of cancer, leading to increasing demand for effective cancer supportive care products.

justinbarnes12
Télécharger la présentation

Global Cancer Supportive Care Products Market - Size, Share, Trends, Analysis to 2021

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Persistence Market Research Global Cancer Supportive Care Products Market is projected to expand at a CAGR of 4.3% by 2015–2021 - Persistence Market Research Persistence Market Research 1

  2. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Persistence Market Research Released New Market Report “Global Cancer Supportive Care Products Market - High consumption of Erythropoietin Stimulating Agents to drive the market for Global Cancer Supportive Care Drugs,” the global cancer supportive care products market is projected to expand at a CAGR of 4.3% during the forecast period (2015–2021). Cancer supportive care products are mainly used in the treatment of adverse effects associated with cancer therapy as well as for treatment of symptoms and signs of cancer, such as chemotherapy-induced nausea and vomiting, chemotherapy induced neutropenia and anemia, bone metastasis, hair loss, etc. The cancer supportive care products market accounted for US$ 23, 6002.0 Mn in 2014 and is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% over the forecast period. Request Customize Full TOC: http://www.persistencemarketresearch.com/toc/5336 The market for cancer supportive care products, though shrouded by the loss of brands exclusivity of various generic drugs and entry of biosimilar drugs, presents lucrative opportunity, as they offer ease of accessibility, affordability, and administration to potential customers. The report analyzes the global cancer supportive care products market in terms of market value (US$ Mn), by drug class, disease indication, region, and distribution channels, and provides information regarding regional market dynamics, regulations, PEST analysis, competitive landscape, current trends, market estimations, and forecast. Among the drug class segments, erythropoietin stimulating agents, such as NeoRecormon, Procrit, and Arsanep, are expected to account for the largest share of the global cancer supportive care products market, followed by granulocyte colony-stimulating factors and others. The erythropoietin stimulating agents segment is expected to gain traction in the near future due to increasing number of patients suffering from chemotherapy-induced neutropenia (low count of neutrophils). Increasing demand for high-quality cancer supportive Persistence Market Research 2

  3. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% care products is also influencing manufacturers to opt for better quality active pharmaceutical ingredients and maintain a sterile microbial contamination-free manufacturing space. By disease indication type, the cancer supportive care products market is segmented into various forms of cancers, such as lung cancer, breast cancer, prostate cancer, etc. Among these, the lung cancer segment is expected to dominate the overall market in future, i.e. by 2021, owing to greater incidences of tobacco smoking cases, rising pollution, and exposure to harmful chemicals and gases released from various industries. The segment is projected to expand at a substantial growth rate over the forecast period. However, breast cancer is also gaining traction due to changing lifestyle, the rise in adoption of hormone replacement therapy, and genetic inheritance of genes such as BRCA1 and BRCA2. Request Sample Report: http://www.persistencemarketresearch.com/samples/5336 Key market participants covered in the report include Amgen Inc., Johnson & Johnson, Novartis Ag., Baxter International Inc, Fagron Group BV, Teva Pharmaceuticals Industries Ltd, Hoffmann LA- Roche Ltd, APR Applied Pharma Science Research S.A., Acacia Pharma Ltd, and Kyowa Hakko Kirin Co Ltd. Buy Full Report: http://www.persistencemarketresearch.com/market-research/cancer- supportive-care-products-market.asp The cancer supportive care products market is segmented as follows: By Drug Class  Non-steroidal anti-inflammatory drugs  Anti-infective  Anti-emetics  Monoclonal antibodies Persistence Market Research 3

  4. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%  Erythropoietin stimulating agents  Opioid analgesics  Bisphosphonates  Granulocyte colony stimulating factors By Disease Indication  Lung cancer  Breast cancer  Prostate cancer  Liver cancer  Bladder cancer  Leukemia  Ovarian cancer  Melanoma  Others By Distribution Channel  Hospital pharmacies  Retail pharmacies  Compounding pharmacies By Region  North America  Latin America  Europe  Asia Pacific  The Middle East & Africa Persistence Market Research 4

  5. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Market History: Progress in cancer treatment procedures, with it, has brought challenges that go beyond cure. Toxicity and morbidity are among the biggest hurdles that a cancer patient has to face while undergoing chemotherapy or radiation therapy. Host of path-breaking technological advancements have been made in the science of supportive care for treating chemotherapy induced side effects, such as bone metastasis, cancer pain, oral mucositis, chemotherapy induced neutropenia, chemotherapy induced nausea and vomiting, chemotherapy induced anemia, and various signs and symptoms associated with it. Cancer supportive care products or drugs are used in the treatment of side effects as well as various signs and symptoms associated with chemotherapy. Drugs used for the treatment of chemotherapy induced side effects belong to one of the drug classes mentioned below: non-steroidal anti- inflammatory drugs, anti-infective, anti-emetics, monoclonal antibodies, erythropoietin stimulating agents, opioid analgesics, bisphosphonates, and granulocyte colony stimulating factors. Globally, cancer supportive care products market is estimated to account for a market value of US$ 24,620 Mn by the end of 2015, and it is projected to witness stable growth across all global regions, due to rising incidences of cancer, leading to increasing demand for effective cancer supportive care products. The primary growth driver for the cancer supportive care products market are the rising incidences of various forms of cancers worldwide. According to Globocan 2012, there were 14.1 Mn cancer cases estimated worldwide in 2012. Lung cancer was seen to be the most common cancer worldwide among men, accounting for nearly 17% of the total number of new cases diagnosed in 2012. Furthermore, greater effectiveness of anti-cancer drugs, such as anti-emetics drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), opioid analgesics drugs, etc., has been driving the growth of the global cancer supportive care products market over the last few years. These drugs help prevent side-effects of cancer treatment on the patient, due to which adoption rate of these cancer supportive care drugs has been on the rise. Manufacturers of cancer supportive care products are more focused on innovation and development of new drugs to maintain a competitive advantage in the market. Many Persistence Market Research 5

  6. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% manufacturers have introduced various new drugs for the treatment of cancer and for therapeutic approaches, including preventive vaccines and cancer supportive care products. Over the last two years, 21 new molecular entities have been launched. These new medicines have increased the possibility of treating cancer, leading to more combination therapies and additional lines of therapy. The rise in overall healthcare expenditure is also expected to contribute to the overall growth of the cancer supportive care products market in the coming years. Healthcare expenditure in the U.S. is projected to grow at an average annual rate of 5.8% during the forecast period. By 2022, healthcare spending in the country is projected to account for around 19.9% of its GDP. This is expected to boost the overall healthcare spending by patients suffering from cancer in the country. Globally, the market in North America is expected to expand at the strongest CAGR in terms of value throughout the forecast period. The U.S. market in North America is estimated to witness a single digit growth during the forecast period. Higher healthcare spending and rising number of initiatives by the government to improve access to various drugs and increase adherence, along with direct-to-consumer marketing in the U.S., are factors that are expected to continue to further drive demand for the cancer supportive care products and, thus, lead to standardization of the market in the region. Currently, erythropoietin stimulating agents segment dominates the region in terms of drug class popularity. However, cost issues and lack of reimbursement policies are expected to slightly hamper the growth of the market in North America during the forecast period. Europe is the second-most lucrative destination for cancer supportive care products currently. Absence of post-treatment patient care in Eastern Europe is expected to affect the overall market for supportive cancer care products in the region over the next few years. The Europe market is expected to expand at a stable CAGR over the forecast period. Major companies based in Europe are looking to expand their base outside Europe to better cater to growing global demand for cancer supportive care products. Brazil is expected to contribute the largest market share in the Latin America cancer supportive care product market and is expected to witness stable growth in terms of market value during the forecast period. However, late diagnosis of cancer that leads to epidemiological transition, wherein the cancer shifts from being an infectious disease to a Persistence Market Research 6

  7. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% chronic disease, is a factor expected to restrict the growth of the overall cancer supportive care products market in Latin America. Globally, the Asia-Pacific market is expected to expand at the highest CAGR, followed by North America, Europe, and Latin America. The Middle East & Africa accounts for a nominal share of the overall cancer supportive care products market currently but is expected to evolve over time with the expansion of infrastructural healthcare facilities and skill base of pharmacists in the region. Key market participants covered in the report include Amgen Inc., Johnson & Johnson, Novartis Ag., Baxter International Inc, Fagron Group BV, Teva Pharmaceuticals Industries Ltd, Hoffmann LA- Roche Ltd, APR Applied Pharma Science Research S.A., Acacia Pharma Ltd, and Kyowa Hakko Kirin Co Ltd. Persistence Market Research 7

  8. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Table of Content 1. Executive Summary 2. Research Methodology 3. Assumption & Acronyms Used 4. Market Overview 4.1. Parent Market Overview 4.2. Market Taxonomy & Market Definition 4.3. Global Cancer Supportive Care Products Market Size and Forecast 4.3.1. Introduction 4.3.2. Market Value Forecast & Y-o-Y Growth Rate (2015-2021) 4.4. Global Cancer Supportive Care Products Market Dynamics 4.4.1. Drivers 4.4.2. Restraints 4.4.3. Trends 4.4.4. Opportunity 5. Regulations & PEST Analysis 6. Global Cancer Supportive Care Products Market Analysis and Forecast By Drug Class 6.1.1. Introduction 6.1.2. Y-o-Y Growth Comparison, By Drug Class 6.1.3. BPS Analysis, By Drug Class 6.1.3.1. Nonsteroidal Anti-inflammatory Drugs 6.1.3.2. Anti-infective 6.1.3.3. Anti-emetics 6.1.3.4. Monoclonal Antibodies 6.1.3.5. Erythropoietin Stimulating Agents 6.1.3.6. Opioid Analgesics 6.1.3.7. Bisphosphonates 6.1.3.8. Granulocyte Colony Stimulating Factor Persistence Market Research 8

  9. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% 6.1.4. Global Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class 7. Global Cancer Supportive Care Products Market Analysis and Forecast By Indication 7.1. Introduction 7.1.1. Y-o-Y Growth Comparison, By Indication 7.1.2. BPS Analysis, By Indication 7.1.2.1. Lung Cancer 7.1.2.2. Breast Cancer 7.1.2.3. Prostate Cancer 7.1.2.4. Liver Cancer 7.1.2.5. Bladder Cancer 7.1.2.6. Leukaemia 7.1.2.7. Ovarian Cancer 7.1.2.8. Melanoma 7.1.2.9. Other Cancer 7.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Indication 8. Cancer Supportive Care Products Market Analysis and Forecast By Distribution Channel 8.1. Introduction 8.1.1. Y-o-Y Growth Comparison, By Distribution Channel 8.1.2. BPS Analysis, By Distribution Channel 8.1.2.1. Hospital Pharmacies 8.1.2.2. Retail Pharmacies 8.1.2.3. Compounding Pharmacies 8.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel 9. Global Cancer Supportive Care Products Market Analysis and Forecast By Region 9.1. Introduction 9.1.1. Y-o-Y Growth Comparison, By Region Persistence Market Research 9

  10. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% 9.1.2. BPS Analysis, By Region 9.1.2.1. North America 9.1.2.2. Latin America 9.1.2.3. Europe 9.1.2.4. Asia Pacific 9.1.2.5. MEA 9.1.3. Global Cancer Supportive Care Products Market Attractiveness Analysis By Region 10. North America Cancer Supportive Care Products Market Analysis 10.1. Introduction 10.2. U.S. 10.2.1. Market Value & Y-o-Y Growth 10.2.2. Absolute $ Opportunity 10.3. Canada 10.3.1. Market Value & Y-o-Y Growth 10.3.2. Absolute $ Opportunity 10.4. North America Cancer Supportive Care Products Market Value By Drug Class 10.5. North America Cancer Supportive Care Products Market Value By Disease Indication 10.6. North America Cancer Supportive Care Products Market Value By Distribution Channel 10.7. North America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class 10.8. North America Cancer Supportive Care Products Market Attractiveness Analysis By Indication 10.9. North America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel 10.10. North America Cancer Supportive Care Products Market Attractiveness Analysis By Country 11. Latin America Cancer Supportive Care Products Market Analysis 11.1. Introduction 11.2. Argentina 11.2.1. Market Value & Y-o-Y Growth 11.2.2. Absolute $ Opportunity 11.3. Brazil 11.3.1. Market Value & Y-o-Y Growth Persistence Market Research 10

  11. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% 11.3.2. Absolute $ Opportunity 11.4. Mexico 11.4.1. Market Value & Y-o-Y Growth 11.4.2. Absolute $ Opportunity 11.5. Rest of Latin America 11.5.1. Market Value & Y-o-Y Growth 11.5.2. Absolute $ Opportunity 11.6. Latin America Cancer Supportive Care Products Market Value By Drug Class 11.7. Latin America Cancer Supportive Care Products Market Value By Disease Indication 11.8. Latin America Cancer Supportive Care Products Market Value By Distribution Channel 11.9. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class 11.10. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Indication 11.11. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel 11.12. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Country 12. Latin America Cancer Supportive Care Products Market Analysis 12.1. Introduction 12.2. Argentina 12.2.1. Market Value & Y-o-Y Growth 12.2.2. Absolute $ Opportunity 12.3. Brazil 12.3.1. Market Value & Y-o-Y Growth 12.3.2. Absolute $ Opportunity 12.4. Mexico 12.4.1. Market Value & Y-o-Y Growth 12.4.2. Absolute $ Opportunity 12.5. Rest of Latin America 12.5.1. Market Value & Y-o-Y Growth 12.5.2. Absolute $ Opportunity 12.6. Latin America Cancer Supportive Care Products Market Value By Drug Class 12.7. Latin America Cancer Supportive Care Products Market Value By Disease Indication Persistence Market Research 11

  12. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% 12.8. Latin America Cancer Supportive Care Products Market Value By Distribution Channel 12.9. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class 12.10. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Indication 12.11. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel 12.12. Latin America Cancer Supportive Care Products Market Attractiveness Analysis By Country 13. Europe Cancer Supportive Care Products Market Analysis 13.1. Introduction 13.2. Germany 13.2.1. Market Value & Y-o-Y Growth 13.2.2. Absolute $ Opportunity 13.3. U.K. 13.3.1. Market Value & Y-o-Y Growth 13.3.2. Absolute $ Opportunity 13.4. France 13.4.1. Market Value & Y-o-Y Growth 13.4.2. Absolute $ Opportunity 13.5. Italy 13.5.1. Market Value & Y-o-Y Growth 13.5.2. Absolute $ Opportunity 13.6. Spain 13.6.1. Market Value & Y-o-Y Growth 13.6.2. Absolute $ Opportunity 13.7. Nordic 13.7.1. Market Value & Y-o-Y Growth 13.7.2. Absolute $ Opportunity 13.8. Russia 13.8.1. Market Value & Y-o-Y Growth 13.8.2. Absolute $ Opportunity 13.9. Rest of Europe 13.9.1. Market Value & Y-o-Y Growth Persistence Market Research 12

  13. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% 13.9.2. Absolute $ Opportunity 13.9.3. 13.10. Europe Cancer Supportive Care Products Market Value By Drug Class 13.11. Europe Cancer Supportive Care Products Market Value By Disease Indication 13.12. Europe Cancer Supportive Care Products Market Value By Distribution Channel 13.13. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class 13.14. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Indication 13.15. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel 13.16. Europe Cancer Supportive Care Products Market Attractiveness Analysis By Country 14. Asia Pacific Cancer Supportive Care Products Market Analysis 14.1. Introduction 14.2. Greater China 14.2.1. Market Value & Y-o-Y Growth 14.2.2. Absolute $ Opportunity 14.3. India 14.3.1. Market Value & Y-o-Y Growth 14.3.2. Absolute $ Opportunity 14.4. Japan 14.4.1. Market Value & Y-o-Y Growth 14.4.2. Absolute $ Opportunity 14.5. Australia and New Zealand 14.5.1. Market Value & Y-o-Y Growth 14.5.2. Absolute $ Opportunity 14.6. Rest of APAC 14.6.1. Market Value & Y-o-Y Growth 14.6.2. Absolute $ Opportunity 14.7. Asia Pacific Cancer Supportive Care Products Market Value By Drug Class 14.8. Asia Pacific Cancer Supportive Care Products Market Value By Disease Indication 14.9. Asia Pacific Cancer Supportive Care Products Market Value By Distribution Channel 14.10. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class Persistence Market Research 13

  14. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% 14.11. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Indication 14.12. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel 14.13. Asia Pacific Cancer Supportive Care Products Market Attractiveness Analysis By Country 15. MEA Cancer Supportive Care Products Market Analysis 15.1. Introduction 15.2. GCC 15.2.1. Market Value & Y-o-Y Growth 15.2.2. Absolute $ Opportunity 15.3. South Africa 15.3.1. Market Value & Y-o-Y Growth 15.3.2. Absolute $ Opportunity 15.4. Rest of MEA 15.4.1. Market Value & Y-o-Y Growth 15.4.2. Absolute $ Opportunity 15.5. MEA Cancer Supportive Care Products Market Value By Drug Class 15.6. MEA Cancer Supportive Care Products Market Value By Disease Indication 15.7. MEA Cancer Supportive Care Products Market Value By Distribution Channel 15.8. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class 15.9. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Indication 15.10. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel 15.11. MEA Cancer Supportive Care Products Market Attractiveness Analysis By Country 16. Competitive Landscape 16.1. Amgen Inc. 16.2. Johnson & Johnson Private Ltd. 16.3. Novartis AG 16.4. Baxter International Inc 16.5. Hoffmann-La Roche Ltd. 16.6. Fagron Group BV 16.7. Teva Pharmaceutical Industries Ltd. Persistence Market Research 14

  15. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% List of Tables Table 01: Global Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn) Table 02: Global Cancer Supportive Care Products Market Value By Disease Indication, 2015– 2021 (US$ Mn) Table 03: Global Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn) Table 04: North America Cancer Supportive Care Products Market Value by Drug Class, 2015– 2021 (US$ Mn) Table 05: North America Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn) Table 06: North America Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn) Table 07: Latin America Cancer Supportive Care Products Market Value by Drug Class, 2015– 2021 (US$ Mn) Table 08: Latin America Cancer Supportive Care Products Market Value By Disease Indication, 2015–2021 (US$ Mn) Table 09: Latin America Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn) Table 10: Europe Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn) Table 11: Europe Cancer Supportive Care Products Market Value By Disease Indication, 2015– 2021 (US$ Mn) Table 12: Europe Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn) Table 13: APAC Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn) Table 14: APAC Cancer Supportive Care Products Market Value By Disease Indication, 2015– 2021 (US$ Mn) Table 15: APAC Cancer Supportive Care Products Market Value By Distribution Channel, 2015–2021 (US$ Mn) Table 16: MEA Cancer Supportive Care Products Market Value by Drug Class, 2015–2021 (US$ Mn) Persistence Market Research 15

  16. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Table 17: MEA Cancer Supportive Care Products Market Value By Disease Indication, 2015– 2021 (US$ Mn) Table 18: MEA Cancer Supportive Care Products Market Value By Distribution Channel, 2015– 2021 (US$ Mn) List of Figures Figure 01: Global Oncology Drug Market Value (US$ Mn) 2014–2021 Figure 02: Global Cancer Supportive Care Drug Market – Scenario Forecast, 2015–2021 (US$ Mn) Figure 03: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 04: Global Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 05: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison By Drug Class, 2015–2021 Figure 06: Cancer Supportive Care Products Market Value Share & BPS Analysis By Drug Class, 2015 & 2021 Figure 07: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Nonsteroidal Anti-inflammatory Drugs, 2015–2021 Figure 08: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Nonsteroidal Anti-inflammatory Drugs, 2015–2021 Figure 09: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Anti- infective, 2015–2021 Figure 10: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Anti- infective, 2015–2021 Figure 11: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Anti- emetics, 2015–2021 Figure 12: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Anti- emetics, 2015–2021 Figure 13: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) Monoclonal Antibodies, 2015–2021 Figure 14: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Monoclonal Antibody, 2015–2021 Persistence Market Research 16

  17. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Figure 15: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Erythropoietin Stimulating Agent, 2015–2021 Figure 16: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Erythropoietin Stimulating Agent, 2015–2021 Figure 17: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Opioid Analgesics, 2015–2021 Figure 18: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Opioid Analgesics, 2015–2021 Figure 19: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Bisphosphonates, 2015–2021 Figure 20: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Bisphosphonates, 2015–2021 Figure 21: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Granulocyte Colony Stimulating Factor, 2015–2021 Figure 22: Global Cancer Supportive Care Products Market Absolute $ Opportunity By Granulocyte Colony Stimulating Factor, 2015–2021 Figure 23: Global Cancer Supportive Care Products Market Attractiveness Analysis By Drug Class, 2015–2021 Figure 24: Global Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021 Figure 25: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison by Indication, 2015–2021 Figure 26: Cancer Supportive Care Products Market Value Share & BPS Analysis by Indication, 2015 & 2021 Figure 27: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Lung Cancer, 2015–2021 Figure 28: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Lung Cancer, 2015–2021 Figure 29: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Breast Cancer, 2015–2021 Figure 30: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Breast Cancer, 2015–2021 Figure 31: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Prostate Cancer, 2015–2021 Persistence Market Research 17

  18. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Figure 32: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Prostate Cancer, 2015–2021 Figure 33: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Liver Cancer, 2015–2021 Figure 34: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Liver Cancer, 2015–2021 Figure 35: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Bladder Cancer, 2015–2021 Figure 36: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Bladder Cancer, 2015–2021 Figure 37: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Leukaemia, 2015–2021 Figure 38: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Leukaemia, 2015–2021 Figure 39: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Ovarian Cancer, 2015–2021 Figure 40: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Ovarian Cancer, 2015–2021 Figure 41: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Melanoma, 2015–2021 Figure 42: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Melanoma, 2015–2021 Figure 43: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Other Cancer, 2015–2021 Figure 44: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Other Cancer 2015–2021 Figure 45: Global Cancer Supportive Care Products Market Y-o-Y Growth Comparison by Distribution Channel, 2015–2021 Figure 46: Cancer Supportive Care Products Market Value Share & BPS Analysis by Distribution Channel, 2015 & 2021 Figure 47: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Hospital Pharmacies, 2015–2021 Figure 48: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Hospital Pharmacies, 2015–2021 Persistence Market Research 18

  19. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Figure 49: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Retail Pharmacies, 2015–2021 Figure 50: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Retail Pharmacies, 2015–2021 Figure 51: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) By Compounding Pharmacies, 2015–2021 Figure 52: Global Cancer Supportive Care Products Market Absolute $ Opportunity by Compounding Pharmacies, 2015–2021 Figure 53: Global Cancer Supportive Care Products Market Attractiveness Analysis by Distribution Channel, 2015–2021 Figure 54: Cancer Supportive Care Products Market Y-o-Y Growth Comparison By Region, 2015–2021 Figure 55: Cancer Supportive Care Products Market Value Share & BPS Analysis By Region, 2015 & 2021 Figure 56: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for North America Region, 2015–2021 Figure 57: Global Cancer Supportive Care Products Market Absolute $ Opportunity for North America Region, 2015–2021 Figure 58: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Latin America Region, 2015–2021 Figure 59: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Latin America Region, 2015–2021 Figure 60: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Europe Region, 2015–2021 Figure 61: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Europe Region, 2015–2021 Figure 62: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Asia Pacific Region, 2015–2021 Figure 63: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Asia Pacific Region, 2015–2021 Figure 64: Global Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) for Middle East and Africa Region, 2015–2021 Figure 65: Global Cancer Supportive Care Products Market Absolute $ Opportunity for Middle East and Africa Region, 2015–2021 Persistence Market Research 19

  20. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Figure 66: Global Cancer Supportive Care Products Market Attractiveness Analysis by Region, 2015–2021 Figure 67: U.S. Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 68: U.S. Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021 Figure 69: Canada Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 70: Canada Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 71: North America Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021 Figure 72: North America Cancer Supportive Care Products Market Attractiveness Analysis by Indication, 2015–2021 Figure 73: North America Cancer Supportive Care Products Market Attractiveness Analysis by Distribution Channel, 2015–2021 Figure 74: North America Cancer Supportive Care Products Market Attractiveness Analysis by Country, 2015–2021 Figure 75: Argentina Cancer Supportive Care Products Market Value & Y-o-Y Growth (%) , 2015–2021 Figure 76: Argentina Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 77: Brazil Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 78: Brazil Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 79: Mexico Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 80: Mexico Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 81: Rest of Latin America Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021 Figure 82: Rest of Latin America Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021 Figure 83: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021 Persistence Market Research 20

  21. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Figure 84: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Indication, 2015–2021 Figure 85: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Distribution Channel, 2015–2021 Figure 86: Latin America Cancer Supportive Care Products Market Attractiveness Analysis by Country, 2015–2021 Figure 87: Germany Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021 Figure 88: Germany Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 89: U.K. Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 90: U.K. Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021 Figure 91: France Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 92: France Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 93: Italy Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 94: Italy Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021 Figure 95: Spain Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 96: Spain Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 97: Nordic Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 98: Nordic Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 99: Russia Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 100: Russia Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 101: Rest Of Europe Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021 Persistence Market Research 21

  22. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Figure 102: Rest Of Europe Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021 Figure 103: Europe Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021 Figure 104: Europe Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021 Figure 105: Europe Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel, 2015–2021 Figure 106: Europe Cancer Supportive Care Products Market Attractiveness Analysis By Country, 2015–2021 Figure 107: Greater China Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021 Figure 108: Greater China Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021 Figure 109: India Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 110: India Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 111: Japan Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 112: Japan Cancer Supportive Care Products Market Absolute $ Opportunity, 2015– 2021 Figure 113: Australia and New Zealand Cancer Supportive Care Products Market Value & Y-o- Y Growth (%), 2015–2021 Figure 114: Australia and New Zealand Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021 Figure 115: Rest of APAC Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021 Figure 116: Rest of APAC Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021 Figure 117: APAC Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021 Figure 118: APAC Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021 Persistence Market Research 22

  23. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% Figure 119: APAC Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel, 2015–2021 Figure 120: APAC Cancer Supportive Care Products Market Attractiveness Analysis By Country, 2015–2021 Figure 121: GCC Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015– 2021 Figure 122: GCC America Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021 Figure 123: South Africa Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021 Figure 124: South Africa Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021 Figure 125: Rest Of MEA Cancer Supportive Care Products Market Value & Y-o-Y Growth (%), 2015–2021 Figure 126: Rest Of MEA Cancer Supportive Care Products Market Absolute $ Opportunity, 2015–2021 Figure 127: MEA Cancer Supportive Care Products Market Attractiveness Analysis by Drug Class, 2015–2021 Figure 128: MEA Cancer Supportive Care Products Market Attractiveness Analysis By Indication, 2015–2021 Figure 129: MEA Cancer Supportive Care Products Market Attractiveness Analysis By Distribution Channel, 2015–2021 Figure 130: MEA Cancer Supportive Care Products Market Attractiveness Analysis By Country, 2015–2021 About Us: Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs. Persistence Market Research 23

  24. Global Cancer Supportive Care Products Market - Market is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values. Contact Us: Persistence Market Research 305 Broadway 7th Floor, New York City, NY 10007, United States, USA - Canada Toll Free: +1 800-961-0353 Email: sales@persistencemarketresearch.com Web: http://www.persistencemarketresearch.com Persistence Market Research 24

More Related